This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsHongda Xingye (002002) 주식 개요Hongda Xingye Co., Ltd. manufactures and sells chemical products in China and internationally. 자세히 보기002002 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적0/6재무 건전성2/6배당0/6위험 분석지난 5년간 매년 수익이 25.1% 감소했습니다.부채는 operating cash flow로 충분히 감당되지 않습니다.주식은 유동성이 매우 낮습니다모든 위험 점검 보기002002 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW473,006 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA473,006 investors already sharing narrativesYour Fair ValueCN¥Current PriceCN¥0.5826.6% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-801m7b2016201920222025202620282031Revenue CN¥2.4bEarnings CN¥225.1mAdvancedSet Fair ValueView all narrativesHongda Xingye Co., Ltd. 경쟁사Maoming Petro-Chemical ShihuaSymbol: SZSE:000637Market cap: CN¥1.9bYangzhou Chenhua New MaterialSymbol: SZSE:300610Market cap: CN¥1.9bShandong Tongda Island New MaterialsLtdSymbol: SZSE:300321Market cap: CN¥2.7bWells Advanced Materials (Shanghai)Symbol: SZSE:301555Market cap: CN¥2.6b가격 이력 및 성과Hongda Xingye 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CN¥0.5852주 최고가CN¥2.9352주 최저가CN¥0.58베타0.671개월 변동0%3개월 변동-40.82%1년 변동-79.06%3년 변동-84.66%5년 변동-89.84%IPO 이후 변동-92.21%최근 뉴스 및 업데이트공고 • Dec 30Hongda Xingye Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024Hongda Xingye Co., Ltd. announced that they will report fiscal year 2023 results on Apr 29, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.003 profit in 3Q 2022)Third quarter 2023 results: CN¥0.11 loss per share (down from CN¥0.003 profit in 3Q 2022). Revenue: CN¥270.7m (down 78% from 3Q 2022). Net loss: CN¥337.2m (down CN¥345.4m from profit in 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.공고 • Oct 19Hongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI IndexHongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI IndexNew Risk • Oct 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings have declined by 17% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.0% average weekly change).Reported Earnings • Aug 31Second quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.057 profit in 2Q 2022)Second quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.057 profit in 2Q 2022). Revenue: CN¥1.11b (down 33% from 2Q 2022). Net loss: CN¥478.4m (down 371% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.Board Change • Aug 04Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.더 많은 업데이트 보기Recent updates공고 • Dec 30Hongda Xingye Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024Hongda Xingye Co., Ltd. announced that they will report fiscal year 2023 results on Apr 29, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.003 profit in 3Q 2022)Third quarter 2023 results: CN¥0.11 loss per share (down from CN¥0.003 profit in 3Q 2022). Revenue: CN¥270.7m (down 78% from 3Q 2022). Net loss: CN¥337.2m (down CN¥345.4m from profit in 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.공고 • Oct 19Hongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI IndexHongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI IndexNew Risk • Oct 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings have declined by 17% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.0% average weekly change).Reported Earnings • Aug 31Second quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.057 profit in 2Q 2022)Second quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.057 profit in 2Q 2022). Revenue: CN¥1.11b (down 33% from 2Q 2022). Net loss: CN¥478.4m (down 371% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.Board Change • Aug 04Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jun 13Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공고 • May 06Hongda Xingye Co., Ltd., Annual General Meeting, May 22, 2023Hongda Xingye Co., Ltd., Annual General Meeting, May 22, 2023, at 15:00 China Standard Time. Agenda: To consider 2022 annual report and its summary; to consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider 2022 profit distribution plan; to consider Confirmation of 2022 continuing connected transactions of the Company and its subsidiaries and 2023 estimated continuing connected transactions; to consider 2022 special report on the deposit and use of raised funds; and to consider other matters.Reported Earnings • Apr 30First quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.033 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.001 (down from CN¥0.033 in 1Q 2022). Revenue: CN¥834.2m (down 8.3% from 1Q 2022). Net income: CN¥1.96m (down 98% from 1Q 2022). Profit margin: 0.2% (down from 11% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.003 (vs CN¥0.21 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.003 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.25b (down 42% from 3Q 2021). Net income: CN¥8.24m (down 99% from 3Q 2021). Profit margin: 0.7% (down from 25% in 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 7% per year.Reported Earnings • Sep 03Second quarter 2022 earnings released: EPS: CN¥0.057 (vs CN¥0.16 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.057 (down from CN¥0.16 in 2Q 2021). Revenue: CN¥1.67b (down 11% from 2Q 2021). Net income: CN¥176.4m (down 66% from 2Q 2021). Profit margin: 11% (down from 28% in 2Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥4.31, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 2.6% over the past three years.Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.033 (vs CN¥0.099 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.033 (down from CN¥0.099 in 1Q 2021). Revenue: CN¥909.4m (down 45% from 1Q 2021). Net income: CN¥102.5m (down 62% from 1Q 2021). Profit margin: 11% (down from 16% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Apr 20Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.31 in FY 2020)Full year 2021 results: EPS: CN¥0.33 (up from CN¥0.31 in FY 2020). Revenue: CN¥6.52b (up 21% from FY 2020). Net income: CN¥851.8m (up 4.7% from FY 2020). Profit margin: 13% (down from 15% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.098 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.14b (up 63% from 3Q 2020). Net income: CN¥538.4m (up 114% from 3Q 2020). Profit margin: 25% (up from 19% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥5.49, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 70% over the past three years.Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥6.45, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 122% over the past three years.Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.055 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.89b (up 60% from 2Q 2020). Net income: CN¥521.9m (up 270% from 2Q 2020). Profit margin: 28% (up from 12% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥4.94, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.Reported Earnings • May 01First quarter 2021 earnings released: EPS CN¥0.099 (vs CN¥0.074 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.64b (up 14% from 1Q 2020). Net income: CN¥269.4m (up 41% from 1Q 2020). Profit margin: 16% (up from 13% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥4.13, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 35x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years.Reported Earnings • Apr 04Full year 2020 earnings released: EPS CN¥0.31 (vs CN¥0.24 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.39b (up 1.8% from FY 2019). Net income: CN¥813.8m (up 29% from FY 2019). Profit margin: 15% (up from 12% in FY 2019). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 18% per year.Valuation Update With 7 Day Price Move • Feb 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥3.72, the stock is trading at a trailing P/E ratio of 13.2x, up from the previous P/E ratio of 11.2x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 43%.Is New 90 Day High Low • Dec 30New 90-day low: CN¥2.95The company is down 22% from its price of CN¥3.80 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Valuation Update With 7 Day Price Move • Dec 18Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥3.18, the stock is trading at a trailing P/E ratio of 11.3x, down from the previous P/E ratio of 13.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 52%.Valuation Update With 7 Day Price Move • Dec 16Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥3.09, the stock is trading at a trailing P/E ratio of 10.9x, down from the previous P/E ratio of 13.5x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 53%.Is New 90 Day High Low • Dec 15New 90-day low: CN¥3.42The company is down 19% from its price of CN¥4.24 on 17 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.Is New 90 Day High Low • Nov 25New 90-day high: CN¥4.28The company is up 9.0% from its price of CN¥3.92 on 27 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Oct 30New 90-day low: CN¥3.60The company is down 8.0% from its price of CN¥3.92 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥726.8m, up 67% from the prior year. Total revenue was CN¥5.17b over the last 12 months, down 10% from the prior year.주주 수익률002002CN ChemicalsCN 시장7D0%1.6%-1.5%1Y-79.1%23.6%7.7%전체 주주 수익률 보기수익률 대 산업: 002002은 지난 1년 동안 23.6%의 수익을 기록한 CN Chemicals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 002002은 지난 1년 동안 7.7%를 기록한 CN 시장보다 저조한 성과를 냈습니다.주가 변동성Is 002002's price volatile compared to industry and market?002002 volatility002002 Average Weekly Movementn/aChemicals Industry Average Movement8.0%Market Average Movement7.4%10% most volatile stocks in CN Market12.4%10% least volatile stocks in CN Market4.4%안정적인 주가: 002002의 주가는 지난 3개월 동안 CN 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine 002002의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트19953,966Yi Feng Zhouwww.002002.cn더 보기Hongda Xingye Co., Ltd. 기초 지표 요약Hongda Xingye의 순이익과 매출은 시가총액과 어떻게 비교됩니까?002002 기초 통계시가총액CN¥1.80b순이익 (TTM)-CN¥800.74m매출 (TTM)CN¥3.21b0.6x주가매출비율(P/S)-2.2x주가수익비율(P/E)002002는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표002002 손익계산서 (TTM)매출CN¥3.21b매출원가CN¥2.85b총이익CN¥362.74m기타 비용CN¥1.16b순이익-CN¥800.74m최근 보고된 실적Sep 30, 2023다음 실적 발표일Apr 29, 2024주당순이익(EPS)-0.26총이익률11.29%순이익률-24.93%부채/자본 비율61.5%002002의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/03/20 10:26종가2024/01/18 00:00수익2023/09/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Hongda Xingye Co., Ltd.는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Xiaofeng QiuEverbright Securities Co. Ltd.Xi LiuHuatai Research
공고 • Dec 30Hongda Xingye Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024Hongda Xingye Co., Ltd. announced that they will report fiscal year 2023 results on Apr 29, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.003 profit in 3Q 2022)Third quarter 2023 results: CN¥0.11 loss per share (down from CN¥0.003 profit in 3Q 2022). Revenue: CN¥270.7m (down 78% from 3Q 2022). Net loss: CN¥337.2m (down CN¥345.4m from profit in 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.
공고 • Oct 19Hongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI IndexHongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI Index
New Risk • Oct 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings have declined by 17% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.0% average weekly change).
Reported Earnings • Aug 31Second quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.057 profit in 2Q 2022)Second quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.057 profit in 2Q 2022). Revenue: CN¥1.11b (down 33% from 2Q 2022). Net loss: CN¥478.4m (down 371% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
Board Change • Aug 04Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Dec 30Hongda Xingye Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024Hongda Xingye Co., Ltd. announced that they will report fiscal year 2023 results on Apr 29, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.003 profit in 3Q 2022)Third quarter 2023 results: CN¥0.11 loss per share (down from CN¥0.003 profit in 3Q 2022). Revenue: CN¥270.7m (down 78% from 3Q 2022). Net loss: CN¥337.2m (down CN¥345.4m from profit in 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.
공고 • Oct 19Hongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI IndexHongda Xingye Co., Ltd.(XSEC:002002) dropped from S&P Global BMI Index
New Risk • Oct 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings have declined by 17% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.0% average weekly change).
Reported Earnings • Aug 31Second quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.057 profit in 2Q 2022)Second quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.057 profit in 2Q 2022). Revenue: CN¥1.11b (down 33% from 2Q 2022). Net loss: CN¥478.4m (down 371% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
Board Change • Aug 04Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jun 13Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • May 06Hongda Xingye Co., Ltd., Annual General Meeting, May 22, 2023Hongda Xingye Co., Ltd., Annual General Meeting, May 22, 2023, at 15:00 China Standard Time. Agenda: To consider 2022 annual report and its summary; to consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider 2022 profit distribution plan; to consider Confirmation of 2022 continuing connected transactions of the Company and its subsidiaries and 2023 estimated continuing connected transactions; to consider 2022 special report on the deposit and use of raised funds; and to consider other matters.
Reported Earnings • Apr 30First quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.033 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.001 (down from CN¥0.033 in 1Q 2022). Revenue: CN¥834.2m (down 8.3% from 1Q 2022). Net income: CN¥1.96m (down 98% from 1Q 2022). Profit margin: 0.2% (down from 11% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.003 (vs CN¥0.21 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.003 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.25b (down 42% from 3Q 2021). Net income: CN¥8.24m (down 99% from 3Q 2021). Profit margin: 0.7% (down from 25% in 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 7% per year.
Reported Earnings • Sep 03Second quarter 2022 earnings released: EPS: CN¥0.057 (vs CN¥0.16 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.057 (down from CN¥0.16 in 2Q 2021). Revenue: CN¥1.67b (down 11% from 2Q 2021). Net income: CN¥176.4m (down 66% from 2Q 2021). Profit margin: 11% (down from 28% in 2Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥4.31, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 2.6% over the past three years.
Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.033 (vs CN¥0.099 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.033 (down from CN¥0.099 in 1Q 2021). Revenue: CN¥909.4m (down 45% from 1Q 2021). Net income: CN¥102.5m (down 62% from 1Q 2021). Profit margin: 11% (down from 16% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Ruihao Liao was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 20Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.31 in FY 2020)Full year 2021 results: EPS: CN¥0.33 (up from CN¥0.31 in FY 2020). Revenue: CN¥6.52b (up 21% from FY 2020). Net income: CN¥851.8m (up 4.7% from FY 2020). Profit margin: 13% (down from 15% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.098 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.14b (up 63% from 3Q 2020). Net income: CN¥538.4m (up 114% from 3Q 2020). Profit margin: 25% (up from 19% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥5.49, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 70% over the past three years.
Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥6.45, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 122% over the past three years.
Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.055 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.89b (up 60% from 2Q 2020). Net income: CN¥521.9m (up 270% from 2Q 2020). Profit margin: 28% (up from 12% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥4.94, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.
Reported Earnings • May 01First quarter 2021 earnings released: EPS CN¥0.099 (vs CN¥0.074 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.64b (up 14% from 1Q 2020). Net income: CN¥269.4m (up 41% from 1Q 2020). Profit margin: 16% (up from 13% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥4.13, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 35x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years.
Reported Earnings • Apr 04Full year 2020 earnings released: EPS CN¥0.31 (vs CN¥0.24 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.39b (up 1.8% from FY 2019). Net income: CN¥813.8m (up 29% from FY 2019). Profit margin: 15% (up from 12% in FY 2019). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 18% per year.
Valuation Update With 7 Day Price Move • Feb 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥3.72, the stock is trading at a trailing P/E ratio of 13.2x, up from the previous P/E ratio of 11.2x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 43%.
Is New 90 Day High Low • Dec 30New 90-day low: CN¥2.95The company is down 22% from its price of CN¥3.80 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥3.18, the stock is trading at a trailing P/E ratio of 11.3x, down from the previous P/E ratio of 13.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 52%.
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥3.09, the stock is trading at a trailing P/E ratio of 10.9x, down from the previous P/E ratio of 13.5x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 53%.
Is New 90 Day High Low • Dec 15New 90-day low: CN¥3.42The company is down 19% from its price of CN¥4.24 on 17 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Nov 25New 90-day high: CN¥4.28The company is up 9.0% from its price of CN¥3.92 on 27 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥3.60The company is down 8.0% from its price of CN¥3.92 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.
Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥726.8m, up 67% from the prior year. Total revenue was CN¥5.17b over the last 12 months, down 10% from the prior year.
